These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 18342566)

  • 41. Role of metalloprotease disintegrin ADAM12 in determination of quiescent reserve cells during myogenic differentiation in vitro.
    Cao Y; Zhao Z; Gruszczynska-Biegala J; Zolkiewska A
    Mol Cell Biol; 2003 Oct; 23(19):6725-38. PubMed ID: 12972593
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Regulation of ADAM12 cell-surface expression by protein kinase C epsilon.
    Sundberg C; Thodeti CK; Kveiborg M; Larsson C; Parker P; Albrechtsen R; Wewer UM
    J Biol Chem; 2004 Dec; 279(49):51601-11. PubMed ID: 15364951
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Inside-out Regulation of Ectodomain Cleavage of Cluster-of-Differentiation-44 (CD44) and of Neuregulin-1 Requires Substrate Dimerization.
    Hartmann M; Parra LM; Ruschel A; Lindner C; Morrison H; Herrlich A; Herrlich P
    J Biol Chem; 2015 Jul; 290(28):17041-54. PubMed ID: 25925953
    [TBL] [Abstract][Full Text] [Related]  

  • 44. ADAM binding protein Eve-1 is required for ectodomain shedding of epidermal growth factor receptor ligands.
    Tanaka M; Nanba D; Mori S; Shiba F; Ishiguro H; Yoshino K; Matsuura N; Higashiyama S
    J Biol Chem; 2004 Oct; 279(40):41950-9. PubMed ID: 15280379
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A disintegrin and metalloproteinase-12 (ADAM12): function, roles in disease progression, and clinical implications.
    Nyren-Erickson EK; Jones JM; Srivastava DK; Mallik S
    Biochim Biophys Acta; 2013 Oct; 1830(10):4445-55. PubMed ID: 23680494
    [TBL] [Abstract][Full Text] [Related]  

  • 46. ADAM12 is expressed by astrocytes during experimental demyelination.
    Baertling F; Kokozidou M; Pufe T; Clarner T; Windoffer R; Wruck CJ; Brandenburg LO; Beyer C; Kipp M
    Brain Res; 2010 Apr; 1326():1-14. PubMed ID: 20176000
    [TBL] [Abstract][Full Text] [Related]  

  • 47. ADAM12 is a prognostic factor associated with an aggressive molecular subtype of high-grade serous ovarian carcinoma.
    Cheon DJ; Li AJ; Beach JA; Walts AE; Tran H; Lester J; Karlan BY; Orsulic S
    Carcinogenesis; 2015 Jul; 36(7):739-47. PubMed ID: 25926422
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Molecular profiling of ADAM12 and ADAM17 genes in human malignant melanoma.
    Cireap N; Narita D
    Pathol Oncol Res; 2013 Oct; 19(4):755-62. PubMed ID: 23645517
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Knockdown of a disintegrin A metalloprotease 12 (ADAM12) during adipogenesis reduces cell numbers, delays differentiation, and increases lipid accumulation in 3T3-L1 cells.
    Coles CA; Maksimovic J; Wadeson J; Fahri FT; Webster T; Leyton C; McDonagh MB; White JD
    Mol Biol Cell; 2018 Aug; 29(15):1839-1855. PubMed ID: 29846135
    [TBL] [Abstract][Full Text] [Related]  

  • 50. ADAM12 and ADAM17 gene expression in laser-capture microdissected and non-microdissected breast tumors.
    Narita D; Seclaman E; Ilina R; Cireap N; Ursoniu S; Anghel A
    Pathol Oncol Res; 2011 Jun; 17(2):375-85. PubMed ID: 21240579
    [TBL] [Abstract][Full Text] [Related]  

  • 51. An essential role of metalloprotease-disintegrin ADAM12 in triple-negative breast cancer.
    Li H; Duhachek-Muggy S; Qi Y; Hong Y; Behbod F; Zolkiewska A
    Breast Cancer Res Treat; 2012 Oct; 135(3):759-69. PubMed ID: 22926263
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Quantitative proteomics identifies myoferlin as a novel regulator of A Disintegrin and Metalloproteinase 12 in HeLa cells.
    Zhou Y; Xiong L; Zhang Y; Yu R; Jiang X; Xu G
    J Proteomics; 2016 Oct; 148():94-104. PubMed ID: 27432471
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Metalloprotease-disintegrin ADAM12 actively promotes the stem cell-like phenotype in claudin-low breast cancer.
    Duhachek-Muggy S; Qi Y; Wise R; Alyahya L; Li H; Hodge J; Zolkiewska A
    Mol Cancer; 2017 Feb; 16(1):32. PubMed ID: 28148288
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Involvement of the serine/threonine p70S6 kinase in TGF-beta1-induced ADAM12 expression in cultured human hepatic stellate cells.
    Le Pabic H; L'Helgoualc'h A; Coutant A; Wewer UM; Baffet G; Clément B; Théret N
    J Hepatol; 2005 Dec; 43(6):1038-44. PubMed ID: 16139919
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Molecular characterization and expression analysis of ADAM12 during chicken embryonic development.
    Lin J; Luo J; Redies C
    Dev Growth Differ; 2010 Dec; 52(9):757-69. PubMed ID: 21158755
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hierarchy of ADAM12 binding to integrins in tumor cells.
    Thodeti CK; Fröhlich C; Nielsen CK; Holck P; Sundberg C; Kveiborg M; Mahalingam Y; Albrechtsen R; Couchman JR; Wewer UM
    Exp Cell Res; 2005 Oct; 309(2):438-50. PubMed ID: 16061220
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Catalytic properties of ADAM12 and its domain deletion mutants.
    Jacobsen J; Visse R; Sørensen HP; Enghild JJ; Brew K; Wewer UM; Nagase H
    Biochemistry; 2008 Jan; 47(2):537-47. PubMed ID: 18081311
    [TBL] [Abstract][Full Text] [Related]  

  • 58. ADAM Metallopeptidase Domain 12 Facilitates Colorectal Cancer Progression by Inhibiting Hippo Signaling Pathway Activity.
    Wang X; Zhu M; Zuo H; Hou G; Xie R
    Mol Cancer Res; 2023 Jun; 21(6):525-534. PubMed ID: 36806444
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Expression and cellular localization of metalloproteases ADAMs in high graded carotid artery lesions.
    Pelisek J; Pongratz J; Deutsch L; Reeps C; Stadlbauer T; Eckstein HH
    Scand J Clin Lab Invest; 2012 Dec; 72(8):648-56. PubMed ID: 23101757
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Increased expression of ADAM12 and ADAM17 genes in laser-capture microdissected breast cancers and correlations with clinical and pathological characteristics.
    Narita D; Seclaman E; Ursoniu S; Anghel A
    Acta Histochem; 2012 Feb; 114(2):131-9. PubMed ID: 21501859
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.